EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Lobular breast cancer statistics, 2025

Angela N Giaquinto iD, Rachel A Freedman, Lisa A Newman iD, Ahmedin Jemal iD, Rebecca L Siegel

Cancer · 2025

DOI: 10.1002/cncr.70061 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer, 2025. Verfasst von Angela N Giaquinto und 4 weiteren Autor:innen. Beteiligte Einrichtung: Surveillance, Prevention, and Health Services Research, American Cancer Society, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Carcinoma, Lobular. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Breast cancer statistics and clinical trial data largely reflect ductal carcinoma, the dominant histologic subtype, concealing important differences for invasive lobular carcinoma (ILC), the second most common subtype.

Methods

Nationally representative cancer registry data from the National Cancer Institute and Centers for Disease Control and Prevention were used to report on the incidence and outcomes of ILC by age, race, and ethnicity among women in the United States.

Results

In 2021 incidence of ILC was 14 per 100,000 women, which accounted for 10.6% of breast cancer diagnoses. Rates increased from 2012 through 2021 in all racial ethnic groups, ranging from 2.5% annually in American Indian/Alaska Native women to 4.4% annually in Asian American/Pacific Islander women. White women have the highest incidence overall (14.7 per 100,000), and in every age group, followed by Black women (11 per 100,000), although American Indian/Alaska Native women have the second‐highest rates among those

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsCarcinoma, LobularHumansFemaleMiddle AgedUnited StatesAgedAdultIncidenceRegistriesAged, 80 and overSEER ProgramYoung AdultCarcinoma, Ductal, Breast

Stichwörter der Autor:innen

breastinvasive lobular carcinomalobularsurvivaltrend

Autor:innen und Institutionen

  • Surveillance, Prevention, and Health Services Research, American Cancer Society, Atlanta, Georgia, USA.
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Surgery, New York-Presbyterian, Weill Cornell Medicine, New York, New York, USA.

ORCID-Profile: Angela N Giaquinto, Lisa A Newman, Ahmedin Jemal

Zitieren

APA

Giaquinto, A. N., Freedman, R. A., Newman, L. A., Jemal, A., & Siegel, R. L. (2025). Lobular breast cancer statistics, 2025. Cancer. https://doi.org/10.1002/cncr.70061

Vancouver

Giaquinto AN, Freedman RA, Newman LA, Jemal A, Siegel RL. Lobular breast cancer statistics, 2025. Cancer. 2025. doi:10.1002/cncr.70061

BibTeX
@article{Giaquinto2025,
  author = {Giaquinto, Angela N and Freedman, Rachel A and Newman, Lisa A and Jemal, Ahmedin and Siegel, Rebecca L},
  title = {Lobular breast cancer statistics, 2025},
  journal = {Cancer},
  year = {2025},
  doi = {10.1002/cncr.70061}
}
Kostenlos starten →